As the holder of the first international value-added medicine patent – liquid Omeprazole, ready to use – Alkaloid sponsored the First International Conference on Modern Approaches to GERD Treatment in Pediatric Patients, held in Zagreb, Croatia.

Intended for Alkaloid’s management team, both domestic and from its entities abroad, this event demonstrates our commitment to enhancing leadership skills and investing in the professional growth and development of our management team.

Since it was first established back in August 1936, Alkaloid has grown and developed through very tumultuous and challenging decades to become the modern, export-oriented company with nearly 3,000 employees that it is today.

Alkaloid AD’s groundbreaking formulation of ready-to-use liquid Omeprazole, a value-added drug representing the world’s first of its kind, has been awarded the 2023 Patent of the Year by the State Office of Industrial Property.

Alkaloid remains dedicated to actively supporting professional and scientific endeavors pivotal for the advancement of pharmacy and medicine, both domestically and internationally.